Healthy4Baby: Preventing Postpartum Weight Retention Among Low-Income, Black Women



Status:Completed
Conditions:Obesity Weight Loss, Women's Studies
Therapuetic Areas:Endocrinology, Reproductive
Healthy:No
Age Range:18 - Any
Updated:5/23/2018
Start Date:January 2012
End Date:March 2016

Use our guide to learn which trials are right for you!

Preventing Postpartum Weight Retention Among Low-Income, Black Women

The purpose of this study is to assess the feasibility and efficacy of an
electronically-mediated, pregnancy and postpartum, behavioral intervention program, compared
to usual obstetric care, on changes in weight and cardiometabolic biomarkers among overweight
and obese Black women.

Black women are in particular need for obesity prevention and treatment. Targeting the
childbearing period has the potential to slow the accumulation of weight gain among this high
risk group. Previous interventions to prevent postpartum weight retention among Blacks are
sparse and limited by poor intervention adherence, high attrition, and failure to include
pregnancy in the study design. The proposed research aims to overcome these shortcomings by
developing an intervention that 1) focuses solely on Black women, 2) incorporates Black
mothers' information needs, values, and social context, 3) uses technology to facilitate
participant engagement, and 4) includes both the pregnancy and postpartum periods.

Inclusion Criteria:

1. Pregnant African-American women at least 18 years of age

2. BMI at recruitment between 25.0-44.9 kg/m2

3. Singleton pregnancy

4. Gestational age of ≤ 20 weeks as determined by last menstrual period

5. Plan to carry the pregnancy to term and keep the baby

6. Own a cell phone with a text messaging plan

7. Member of Facebook social networking site

8. Able to participate in physical activity

9. Participants must be willing to comply with all study-related procedures

Exclusion Criteria:

1. BMI ≤ 24.9 or ≥ 45.0

2. Uncontrolled hypertension (systolic blood pressure > 160 or diastolic blood pressure >
95 mmHg). Participants with controlled hypertension on medication for at least three
months are allowable.

3. Known atherosclerotic cardiovascular disease

4. Known congestive heart failure

5. Known diabetes mellitus (type 1 or type 2)

6. Uncontrolled thyroid disease. Participants with controlled thyroid disease on
medication for at least three months are allowable.

7. Known cancer

8. Any major active rheumatologic, pulmonary, hepatic, dermatologic disease or
inflammatory condition requiring steroids or immune modulating medications

9. History of testing HIV positive

10. Current smoker or tobacco user

11. Current or recent history (past 6 months) of drug or alcohol abuse or dependence

12. Participation in any weight control or investigational drug study within 6 weeks of
screening

13. Serious or unstable medical or psychological conditions that, in the opinion of the
investigator, would compromise the subject's safety for successful study participation

14. Gastrointestinal Disorders (gallbladder disease, Crohn's disease, etc)

15. Previous weight loss surgery

16. History of bulimia or anorexia
We found this trial at
1
site
1801 N Broad St
Philadelphia, Pennsylvania 19122
(215) 204-7000
Temple University Temple University is many things to many people. A place to pursue life's...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials